Literature DB >> 12808053

Biphasic estradiol-induced AKT phosphorylation is modulated by PTEN via MAP kinase in HepG2 cells.

Maria Marino1, Filippo Acconcia, Anna Trentalance.   

Abstract

We reported previously in HepG2 cells that estradiol induces cell cycle progression throughout the G1-S transition by the parallel stimulation of both PKC-alpha and ERK signaling molecules. The analysis of the cyclin D1 gene expression showed that only the MAP kinase pathway was involved. Here, the presence of rapid/nongenomic, estradiol-regulated, PI3K/AKT signal transduction pathway, its modulation by the levels of the tumor suppressor PTEN, its cross-talk with the ERK pathway, and its involvement in DNA synthesis and cyclin D1 gene promoter activity have all been studied in HepG2 cells. 17beta-Estradiol induced the rapid and biphasic phosphorylation of AKT. These phosphorylations were independent of each other, being the first wave of activation independent of the estrogen receptor (ER), whereas the second was dependent on ER. Both activations were dependent on PI3K activity; furthermore, the ERK pathway modulated AKT phosphorylation by acting on the PTEN levels. The results showed that the PI3K pathway, as well as ER, were strongly involved in both G1-S progression and cyclin D1 promoter activity by acting on its proximal region (-254 base pairs). These data indicate that in HepG2 cells, different rapid/nongenomic estradiol-induced signal transduction pathways modulate the multiple steps of G1-S phase transition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12808053      PMCID: PMC194905          DOI: 10.1091/mbc.e02-09-0621

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  53 in total

1.  Immunolocalisation of oestrogen receptor beta in human tissues.

Authors:  A H Taylor; F Al-Azzawi
Journal:  J Mol Endocrinol       Date:  2000-02       Impact factor: 5.098

2.  Transcriptional activation of the cyclin D1 gene is mediated by multiple cis-elements, including SP1 sites and a cAMP-responsive element in vascular endothelial cells.

Authors:  D Nagata; E Suzuki; H Nishimatsu; H Satonaka; A Goto; M Omata; Y Hirata
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

Review 3.  PI3-kinase inhibition: a target for drug development?

Authors:  R C Stein; M D Waterfield
Journal:  Mol Med Today       Date:  2000-09

4.  Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling.

Authors:  K S Russell; M P Haynes; D Sinha; E Clerisme; J R Bender
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

5.  Increased mitochondrial superoxide production in rat liver mitochondria, rat hepatocytes, and HepG2 cells following ethinyl estradiol treatment.

Authors:  J Chen; Y Li; J A Lavigne; M A Trush; J D Yager
Journal:  Toxicol Sci       Date:  1999-10       Impact factor: 4.849

6.  Differential effects of estradiol and estradiol-BSA conjugates.

Authors:  P E Stevis; D C Deecher; L Suhadolnik; L M Mallis; D E Frail
Journal:  Endocrinology       Date:  1999-11       Impact factor: 4.736

7.  Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis.

Authors:  E K Lobenhofer; G Huper; J D Iglehart; J R Marks
Journal:  Cell Growth Differ       Date:  2000-02

8.  Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors.

Authors:  P Roger; M E Sahla; S Mäkelä; J A Gustafsson; P Baldet; H Rochefort
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

9.  Steroids conjugated to bovine serum albumin as tools to demonstrate specific steroid neuronal membrane binding sites.

Authors:  J Zheng; A Ali; V D Ramirez
Journal:  J Psychiatry Neurosci       Date:  1996-05       Impact factor: 6.186

Review 10.  The significance of heregulin in breast cancer tumor progression and drug resistance.

Authors:  R Lupu; M Cardillo; C Cho; L Harris; M Hijazi; C Perez; K Rosenberg; D Yang; C Tang
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

View more
  27 in total

Review 1.  Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression.

Authors:  Priya Bhardwaj; CheukMan C Au; Alberto Benito-Martin; Heta Ladumor; Sofya Oshchepkova; Ruth Moges; Kristy A Brown
Journal:  J Steroid Biochem Mol Biol       Date:  2019-03-06       Impact factor: 4.292

Review 2.  Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Authors:  Mark A Feitelson; Alla Arzumanyan; Rob J Kulathinal; Stacy W Blain; Randall F Holcombe; Jamal Mahajna; Maria Marino; Maria L Martinez-Chantar; Roman Nawroth; Isidro Sanchez-Garcia; Dipali Sharma; Neeraj K Saxena; Neetu Singh; Panagiotis J Vlachostergios; Shanchun Guo; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Alan Bilsland; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; W Nicol Keith; Somaira Nowsheen
Journal:  Semin Cancer Biol       Date:  2015-04-17       Impact factor: 15.707

3.  Molecular mechanisms of bladder outlet obstruction in transgenic male mice overexpressing aromatase (Cyp19a1).

Authors:  Wei Lin; Nafis A Rahman; Jian Lin; Hua Zhang; Kemian Gou; Wanpeng Yu; Dahai Zhu; Ning Li; Ilpo Huhtaniemi; Xiangdong Li
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

4.  Nutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities.

Authors:  Paola Galluzzo; Maria Marino
Journal:  Genes Nutr       Date:  2006-09       Impact factor: 5.523

Review 5.  Xenoestrogens challenge 17β-estradiol protective effects in colon cancer.

Authors:  Maria Marino
Journal:  World J Gastrointest Oncol       Date:  2014-03-15

6.  Human myeloblastic leukemia cells (HL-60) express a membrane receptor for estrogen that signals and modulates retinoic acid-induced cell differentiation.

Authors:  M Ariel Kauss; Gudrun Reiterer; Rodica P Bunaciu; Andrew Yen
Journal:  Exp Cell Res       Date:  2008-07-26       Impact factor: 3.905

7.  Rapid activation of ERK1/2 and AKT in human breast cancer cells by cadmium.

Authors:  Zhiwei Liu; Xinyuan Yu; Zahir A Shaikh
Journal:  Toxicol Appl Pharmacol       Date:  2007-12-27       Impact factor: 4.219

8.  Estrogen rapidly activates the PI3K/AKT pathway and hypoxia-inducible factor 1 and induces vascular endothelial growth factor A expression in luminal epithelial cells of the rat uterus.

Authors:  Armina A Kazi; Kristin Happ Molitoris; Robert D Koos
Journal:  Biol Reprod       Date:  2009-05-06       Impact factor: 4.285

9.  Estrogen signaling multiple pathways to impact gene transcription.

Authors:  Maria Marino; Paola Galluzzo; Paolo Ascenzi
Journal:  Curr Genomics       Date:  2006       Impact factor: 2.236

10.  Luteinizing hormone-induced Akt phosphorylation and androgen production are modulated by MAP Kinase in bovine theca cells.

Authors:  Shin Fukuda; Makoto Orisaka; Kimihisa Tajima; Katsushige Hattori; Fumikazu Kotsuji
Journal:  J Ovarian Res       Date:  2009-11-16       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.